Baxter Bros Inc Eli Lilly & CO Transaction History

Baxter Bros Inc

$762 Million
Q3 2024

A detailed history of Baxter Bros Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Baxter Bros Inc holds 1,978 shares of LLY stock, worth $1.57 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

1,978

Previous 1,958 1.02%

Holding current value

$1.57 Million

Previous $1.77 Million 1.13%

% of portfolio

0.23%

Previous 0.23%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$772.14 - $960.02 $15,442 - $19,200	20 Added 1.02%	1,978 $1.75 Million
Q1 2024 Apr 26, 2024	SELL	$592.2 - $792.28 $103,635 - $138,649	-175 Reduced 8.2%	1,958 $1.52 Million
Q4 2023 May 17, 2024	BUY	$525.19 - $619.13 $91,908 - $108,347	175 Added 8.94%	2,133 $1.24 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $2,625 - $3,095	-5 Reduced 0.23%	2,133 $1.24 Million
Q3 2023 May 17, 2024	BUY	$434.7 - $599.3 $78,246 - $107,873	180 Added 9.19%	2,138 $1.15 Million
Q3 2023 Oct 23, 2023	SELL	$434.7 - $599.3 $4,347 - $5,993	-10 Reduced 0.47%	2,138 $1.15 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $28,760 - $38,456	-82 Reduced 3.68%	2,148 $1.01 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $9,318 - $10,944	-30 Reduced 1.33%	2,230 $765,000
Q4 2022 Jan 31, 2023	SELL	$321.55 - $374.67 $8,038 - $9,366	-25 Reduced 1.09%	2,260 $826,000
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $29,648 - $33,787	-100 Reduced 4.19%	2,285 $739,000
Q3 2021 Oct 25, 2021	BUY	$221.6 - $272.71 $1,108 - $1,363	5 Added 0.21%	2,385 $551,000
Q2 2021 Aug 11, 2021	BUY	$180.55 - $233.54 $13,541 - $17,515	75 Added 3.25%	2,380 $546,000
Q4 2020 Jan 25, 2021	BUY	$130.46 - $172.63 $300,710 - $397,912	2,305 New	2,305 $389,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baxter Bros Inc, based on Form 13F filings with the SEC.

News

Stay updated on Baxter Bros Inc with notifications on news.

Account